E. Burton

发表

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

R. S. Rogers, C. Koboldt, K. Seibert, 1997, Journal of medicinal chemistry.

1,2‐Diarylcyclopentenes as Selective Cyclooxygenase‐2 Inhibitors and Orally Active anti‐Inflammatory Agents.

C. Koboldt, K. Seibert, P. Isakson, 1996 .

Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data

E. Burton, L. Berry, C. Cook, 2004, Xenobiotica; the fate of foreign compounds in biological systems.

The substrate specificity of 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase.

E. Burton, J. Selhub, W. Sakami, 1969, The Biochemical journal.

Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.

E. Burton, L. I. Goldberg, C. E. McCoy, 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[189] Methionine biosynthesis (yeast)

E. Burton, W. Sakami, 1971 .

1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents.

C. Koboldt, P. Isakson, S. Gregory, 1995, Journal of medicinal chemistry.

Regulation of methionine biosynthesis in Neurospora crassa

R. Metzenberg, E. Burton, R. L. Metzenberg, 1975 .

Novel Mutation Causing Derepression of Several Enzymes of Sulfur Metabolism in Neurospora crassa

R. Metzenberg, E. Burton, R. L. Metzenberg, 1972, Journal of bacteriology.

Properties of repressible alkaline phosphates from wild type and a wall-less mutant of Neurospora crassa.

R. Metzenberg, E. Burton, 1974, The Journal of biological chemistry.

Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.

J Y Zhang, E. Burton, J. Cogburn, 2000, Drug metabolism and disposition: the biological fate of chemicals.

The formation of methionine from the monoglutamate form of methyltetrahydrofolate by higher plants.

E. Burton, W. Sakami, 1969, Biochemical and biophysical research communications.

Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5.

E. Burton, L. Berry, J. Hribar, 2002, Drug metabolism and disposition: the biological fate of chemicals.

Plasma protein binding of celecoxib in mice, rat, rabbit, dog and human

E. Burton, D. Fast, M. Baratta, 1999, Biopharmaceutics & drug disposition.

Methylenetetrahydrofolate reductase in the rat central nervous system: intracellular and regional distribution.

E. Burton, H. J. Sallach, 1975, Archives of biochemistry and biophysics.

INVOLVEMENT OF CYP 3 A IN THE METABOLISM OF EPLERENONE IN HUMANS AND DOGS : DIFFERENTIAL METABOLISM BY CYP 3 A 4 AND CYP 3 A 5

E. Burton, L. Berry, J. Hribar, 2002 .

Preliminary Studies on Bemitradine-Induced Cardiotoxicity in Female Rats

E. Burton, G. Walsh, S. Levin, 1991 .

Promotional activities of the non‐genotoxic carcinogen bemitradine (SC‐33643)

E. Burton, S. Gad, C. Chengelis, 1992, Journal of applied toxicology : JAT.

Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationships.

C. Koboldt, K. Seibert, P. Isakson, 1996, Journal of medicinal chemistry.

Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib.

E. Burton, B. Reitz, B. Reitz, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Absorption by the rhesus monkey of phenylalanine methyl ester and species differences in its metabolism by blood, plasma and intestinal mucosa.

E. Burton, P. Dal Monte, J. Oppermann, 1984, The Journal of nutrition.